Issues
-
Cover Image
Cover Image
Centrosome amplification is frequently found in both solid tumors and hematological malignancies. Experimentally, supernumerary centrosomes can be induced by overexpression of polo-like kinase 4 (PLK4), the principal regulator of centriole replication. The image depicts a large human osteosarcoma cell, which harbors numerous spindle poles as a consequence of exogenous PLK4 overexpression. In early prophase, chromatin condensation is accompanied by the separation of centrosomes and recruitment of the mitotic kinesin Eg5 (green) to spindle poles and proximal asters. For details, see article by Konotop and colleagues on page 6690. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Cancer Research
Table of Contents
Breaking Advances
Cancer Research 75th Anniversary Commentaries
Reviews
Perspective
Integrated Systems and Technologies
Microenvironment and Immunology
CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Molecular and Cellular Pathobiology
Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer
Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell–Like Behaviors in Hepatocellular Carcinoma
IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma
Prevention and Epidemiology
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
Therapeutics, Targets, and Chemical Biology
Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
Tumor and Stem Cell Biology
v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.